Statistics
Publications
35
Citations
8.7K
H-Index
26
Active since
1996
Andrew Albright is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, oncology, and medicine.
Publications per year
1996–2022
35
35
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers, Jared Lunceford, Michael Nebozhyn et al. · Journal of Clinical Investigation · 2017 · 3.9K citations · Full text
Medicine, Immunology, Oncology +17
Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy
Răzvan Cristescu, Robin Mogg, Mark Ayers et al. · Science · 2018 · 2.3K citations
Medicine, Immunology, Oncology +17
Andrew Albright, Joseph T.C. Shieh, Takayuki Itoh et al. · Journal of Virology · 1999 · 295 citations · Full text
Antoni Ribas, Caroline Robert, F. Stephen Hodi et al. · Journal of Clinical Oncology · 2015 · 199 citations
Life Sciences, Immunology, Oncology +17
1–5 of 35